INR 57.44
(2.85%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 150.37 Million INR | -3.67% |
2022 | 135.66 Million INR | 42.55% |
2021 | 93.33 Million INR | 15.92% |
2020 | 62.59 Million INR | 72.16% |
2019 | 49.37 Million INR | 8.25% |
2018 | 46.64 Million INR | 6.9% |
2017 | 43.94 Million INR | -1.45% |
2016 | 40.7 Million INR | 5.93% |
2015 | 38.99 Million INR | 29.19% |
2014 | 31.77 Million INR | 30.3% |
2013 | 23.16 Million INR | 52.66% |
2012 | 15.17 Million INR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 28.1 Million INR | -40.65% |
2023 Q3 | 30.05 Million INR | -25.5% |
2023 Q4 | 46.45 Million INR | 54.6% |
2023 FY | - INR | -3.67% |
2023 Q1 | 27.68 Million INR | -8.87% |
2023 Q2 | 40.33 Million INR | 45.68% |
2022 Q4 | 30.38 Million INR | -28.54% |
2022 Q3 | 42.51 Million INR | -9.48% |
2022 Q2 | 46.97 Million INR | 232.62% |
2022 Q1 | 14.12 Million INR | -54.06% |
2022 FY | - INR | 42.55% |
2021 Q4 | 30.73 Million INR | 42.89% |
2021 Q1 | 8.72 Million INR | -12.09% |
2021 Q2 | 29.63 Million INR | 239.54% |
2021 Q3 | 21.51 Million INR | -27.4% |
2021 FY | - INR | 15.92% |
2020 Q2 | 16.27 Million INR | 0.0% |
2020 Q4 | 9.92 Million INR | 0.0% |
2020 Q3 | 9.92 Million INR | -38.99% |
2020 Q1 | 16.27 Million INR | 159.35% |
2020 FY | - INR | 72.16% |
2019 Q3 | 6.27 Million INR | -21.35% |
2019 Q1 | 7.97 Million INR | -42.51% |
2019 FY | - INR | 8.25% |
2019 Q4 | 6.27 Million INR | 0.0% |
2019 Q2 | 7.97 Million INR | 0.0% |
2018 Q4 | 13.87 Million INR | 0.0% |
2018 FY | - INR | 6.9% |
2018 Q3 | 13.87 Million INR | 544.9% |
2018 Q1 | 2.15 Million INR | -79.75% |
2018 Q2 | 2.15 Million INR | 0.0% |
2017 FY | - INR | -1.45% |
2017 Q1 | 8.37 Million INR | 0.0% |
2017 Q2 | 8.37 Million INR | 0.0% |
2017 Q3 | 10.62 Million INR | 26.87% |
2017 Q4 | 10.62 Million INR | 0.0% |
2016 FY | - INR | 5.93% |
2015 FY | - INR | 29.19% |
2014 FY | - INR | 30.3% |
2013 FY | - INR | 52.66% |
2012 FY | - INR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Alembic Pharmaceuticals Limited | 9.61 Billion INR | 98.436% |
Aurobindo Pharma Limited | 61.78 Billion INR | 99.757% |
Glenmark Life Sciences Limited | 6.86 Billion INR | 97.809% |
Granules India Limited | 8.6 Billion INR | 98.252% |
Indoco Remedies Limited | 2.64 Billion INR | 94.319% |
Achyut Healthcare Limited | 524 Thousand INR | -28598.092% |
Ajanta Pharma Limited | 12.56 Billion INR | 98.803% |
Alkem Laboratories Limited | 24.19 Billion INR | 99.378% |
Alpa Laboratories Limited | 86.12 Million INR | -74.6% |
Brooks Laboratories Limited | 41.72 Million INR | -260.377% |
AstraZeneca Pharma India Limited | 2.35 Billion INR | 93.619% |
Bajaj HealthCare Limited | 444.51 Million INR | 66.17% |
Bliss GVS Pharma Limited | 1.47 Billion INR | 89.833% |
Dr. Reddy's Laboratories Limited | 88.27 Billion INR | 99.83% |
Eris Lifesciences Limited | 6.98 Billion INR | 97.848% |
FDC Limited | 4.4 Billion INR | 96.584% |
Glenmark Pharmaceuticals Limited | 11.34 Billion INR | 98.674% |
Gufic Biosciences Limited | 1.48 Billion INR | 89.843% |
Ind-Swift Laboratories Limited | 6.86 Billion INR | 97.808% |
Ipca Laboratories Limited | 13.29 Billion INR | 98.869% |
Jagsonpal Pharmaceuticals Limited | 323.46 Million INR | 53.51% |
Krebs Biochemicals & Industries Limited | -82.72 Million INR | 281.776% |
Lasa Supergenerics Limited | -65.08 Million INR | 331.066% |
Laurus Labs Limited | 8 Billion INR | 98.122% |
Lupin Limited | 36.96 Billion INR | 99.593% |
Mankind Pharma Limited | 28.09 Billion INR | 99.465% |
Medicamen Biotech Limited | 245.66 Million INR | 38.786% |
Megasoft Limited | 284.73 Million INR | 47.186% |
NATCO Pharma Limited | 18.79 Billion INR | 99.2% |
Piramal Pharma Limited | 13.05 Billion INR | 98.848% |
RPG Life Sciences Limited | 1.28 Billion INR | 88.265% |
Sigachi Industries Limited | 883.39 Million INR | 82.977% |
Sun Pharmaceutical Industries Limited | 138.36 Billion INR | 99.891% |
Suven Pharmaceuticals Limited | 4.67 Billion INR | 96.785% |
Syncom Formulations (India) Limited | 430.27 Million INR | 65.051% |
Unichem Laboratories Limited | 742.35 Million INR | 79.743% |
Wanbury Limited | 985.49 Million INR | 84.741% |
Windlas Biotech Limited | 781.72 Million INR | 80.763% |
ZIM Laboratories Limited | 462.09 Million INR | 67.457% |
Zydus Lifesciences Limited | 56.22 Billion INR | 99.733% |
Sun Pharma Advanced Research Company Limited | -3.73 Billion INR | 104.03% |
Divi's Laboratories Limited | 25.43 Billion INR | 99.409% |
Hester Biosciences Limited | 539.47 Million INR | 72.125% |
Procter & Gamble Health Limited | 3.01 Billion INR | 95.011% |
Amrutanjan Health Care Limited | 682.53 Million INR | 77.968% |
Bal Pharma Limited | 345.59 Million INR | 56.487% |
Strides Pharma Science Limited | 3.76 Billion INR | 96.006% |
Venus Remedies Limited | 711.8 Million INR | 78.874% |
Aarti Pharmalabs Limited | 3.9 Billion INR | 96.153% |
Nectar Lifesciences Limited | 1.56 Billion INR | 90.384% |
Shilpa Medicare Limited | 2.58 Billion INR | 94.189% |
Aarti Drugs Limited | 3.24 Billion INR | 95.371% |
IOL Chemicals and Pharmaceuticals Limited | 2.6 Billion INR | 94.231% |
Suven Life Sciences Limited | -992.78 Million INR | 115.147% |
Ind-Swift Limited | 1.06 Billion INR | 85.881% |
Valiant Laboratories Limited | 12.73 Million INR | -1080.454% |
J. B. Chemicals & Pharmaceuticals Limited | 9.33 Billion INR | 98.389% |
Solara Active Pharma Sciences Limited | -2.82 Billion INR | 105.329% |
Themis Medicare Limited | 562.6 Million INR | 73.271% |
Hikal Limited | 2.69 Billion INR | 94.414% |
Torrent Pharmaceuticals Limited | 35 Billion INR | 99.57% |
Sequent Scientific Limited | 549.8 Million INR | 72.649% |
Novartis India Limited | 1.26 Billion INR | 88.153% |
Wockhardt Limited | 1.08 Billion INR | 86.076% |
Jubilant Pharmova Limited | 8 Billion INR | 98.122% |
Biofil Chemicals and Pharmaceuticals Limited | 13.06 Million INR | -1051.263% |
Neuland Laboratories Limited | 4.74 Billion INR | 96.833% |
Morepen Laboratories Limited | 1.72 Billion INR | 91.287% |
Kilitch Drugs (India) Limited | 287.42 Million INR | 47.681% |
Mangalam Drugs & Organics Limited | 174.94 Million INR | 14.043% |